<?xml version="1.0"?>
<metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/"><dc:title>Covalent inhibitors of bacterial peptidoglycan biosynthesis enzyme MurA with chloroacetamide warhead</dc:title><dc:creator>Grabrijan,	Katarina	(Avtor)
	</dc:creator><dc:creator>Hrast Rambaher,	Martina	(Avtor)
	</dc:creator><dc:creator>Proj,	Matic	(Avtor)
	</dc:creator><dc:creator>Dolšak,	Ana	(Avtor)
	</dc:creator><dc:creator>Zdovc,	Irena	(Avtor)
	</dc:creator><dc:creator>Imre,	Tímea	(Avtor)
	</dc:creator><dc:creator>Petri,	László	(Avtor)
	</dc:creator><dc:creator>Ábrányi-Balogh,	Péter	(Avtor)
	</dc:creator><dc:creator>Keserü M.,	György	(Avtor)
	</dc:creator><dc:creator>Gobec,	Stanislav	(Avtor)
	</dc:creator><dc:subject>antibacterial agents</dc:subject><dc:subject>UDP-N-acetylglucosamine enolpyruvyl transferase</dc:subject><dc:subject>thiol reactivity</dc:subject><dc:description>MurA (UDP-N-acetylglucosamine enolpyruvyl transferase) catalyzes the first committed step in the cytoplasmic part of peptidoglycan biosynthesis and is a validated target enzyme for antibacterial drug discovery; the inhibitor fosfomycin has been used clinically for decades. Like fosfomycin, most MurA inhibitors are small heterocyclic compounds that inhibit the enzyme by forming a covalent bond with the active site cysteine. The reactive chloroacetamide group was selected from a series of suitable electrophilic thiol-reactive warheads. The predominantly one-step synthesis led to the construction of the final library of 47 fragment-sized chloroacetamide compounds. Several new E. coli MurA inhibitors were identified, with the most potent compound having an IC$_{50}$ value in the low micromolar range. The electrophilic reactivity of all chloroacetamide fragments in our library was evaluated by a high-throughput spectrophotometric assay using the reduced Ellman reagent as a surrogate for the cysteine thiol. LC-MS/MS experiments confirmed the covalent binding of the most potent inhibitor to Cys115 of the digested MurA enzyme. The covalent binding was further investigated by a biochemical time-dependent assay and a dilution assay, which confirmed the irreversible and time-dependent mode of action. The efficacy of chloroacetamide derivatives against MurA does not correlate with their thiol reactivity, making the active fragments valuable starting points for fragment-based development of new antibacterial agents targeting MurA.</dc:description><dc:date>2022</dc:date><dc:date>2022-09-29 10:12:24</dc:date><dc:type>Članek v reviji</dc:type><dc:identifier>141439</dc:identifier><dc:identifier>UDK: 579.8:615.4:54</dc:identifier><dc:identifier>ISSN pri članku: 0223-5234</dc:identifier><dc:identifier>DOI: 10.1016/j.ejmech.2022.114752</dc:identifier><dc:identifier>COBISS_ID: 123442179</dc:identifier><dc:language>sl</dc:language></metadata>
